Ethic Inc. Buys 12,989 Shares of Rocket Lab Corporation $RKLB

Key Points

• Ethic Inc. increased its Rocket Lab stake by 14.3%, purchasing 12,989 shares in the third quarter to reach 103,795 shares valued at about $7.23 million.
• Rocket Lab’s third-quarter revenue climbed 72.7% year over year to $267.8 million, beating estimates, and it reported record backlog growth. However, its $0.12-per-share loss was wider than expected, and Neutron’s first launch is now anticipated in 2027.
• Analysts’ consensus rating was “Moderate Buy,” with a consensus price target of $102.05.

Ethic Inc. boosted its stake in shares of Rocket Lab Corporation (NASDAQ:RKLB - Free Report) by 14.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 103,795 shares of the rocket manufacturer's stock after buying an additional 12,989 shares during the period. Ethic Inc.'s holdings in Rocket Lab were worth $7,232,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in shares of Rocket Lab during the 2nd quarter worth approximately $4,124,970,000. Bank of America Corp DE purchased a new stake in Rocket Lab in the second quarter valued at approximately $437,280,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Rocket Lab by 14.8% in the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,737,451 shares of the rocket manufacturer's stock valued at $278,262,000 after purchasing an additional 352,094 shares during the period. Bank of New York Mellon Corp acquired a new position in Rocket Lab during the second quarter worth $245,764,000. Finally, Amundi lifted its stake in Rocket Lab by 22.2% during the second quarter. Amundi now owns 2,180,748 shares of the rocket manufacturer's stock worth $221,673,000 after purchasing an additional 396,639 shares in the last quarter. Institutional investors and hedge funds own 71.78% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Citizens Jmp dropped their price objective on Rocket Lab from $130.00 to $90.00 and set a "market outperform" rating for the company in a research note on Friday, October 16th. Bank of America decreased their target price on Rocket Lab from $115.00 to $110.00 and set a "buy" rating on the stock in a research note on Monday, August 31st. Raymond James Financial assumed coverage on Rocket Lab in a research note on Friday, September 11th. They set an "outperform" rating and a $80.00 target price on the stock. Roth Capital restated a "buy" rating on shares of Rocket Lab in a report on Thursday, October 15th. Finally, TD Cowen reaffirmed a "buy" rating and issued a $90.00 target price on shares of Rocket Lab in a research report on Thursday, October 15th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $102.05.

Key Stories Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Revenue rose 72.7% year over year to $267.8 million, beating analyst estimates. The company also reported record backlog growth of $1.2 billion, or 52% sequentially, positive GAAP operating cash flow, and forecast fourth-quarter revenue of about $280 million at the midpoint with gross-margin expansion. Rocket Lab Q3 2026 results
• Positive Sentiment: Rocket Lab secured more than $515 million in Neutron launch deals during the quarter. The rocket’s backlog reached 16 missions, and the company raised its base launch price to $70 million for several missions—evidence of customer demand ahead of Neutron’s debut. Neutron launch deals
• Negative Sentiment: The quarterly loss was $0.12 per share, wider than analysts’ expected $0.07 loss. Reports attributed the after-hours share decline to the earnings miss, despite the revenue beat and stronger outlook. Rocket Lab shares fall after earnings miss
• Negative Sentiment: Neutron’s first launch is now expected in 2027, extending a key execution risk for investors even as the launch vehicle’s customer backlog grows. Neutron debut delay

Rocket Lab Stock Up 10.9%

Shares of RKLB opened at $58.86 on Tuesday. Rocket Lab Corporation has a fifty-two week low of $37.57 and a fifty-two week high of $151.00. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01. The firm's 50 day moving average price is $62.45 and its 200 day moving average price is $78.80.

Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its quarterly earnings results on Monday, November 9th. The rocket manufacturer reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.05). The company had revenue of $267.83 million for the quarter, compared to analysts' expectations of $257.21 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. As a group, analysts predict that Rocket Lab Corporation will post -0.20 EPS for the current fiscal year.

Insider Buying and Selling at Rocket Lab

In other news, SVP Arjun Kampani sold 7,754 shares of the business's stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $539,911.02. Following the completion of the transaction, the senior vice president directly owned 256,951 shares of the company's stock, valued at approximately $17,891,498.13. The trade was a 2.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Adam Spice sold 140,157 shares of the company's stock in a transaction that occurred on Thursday, October 1st. The stock was sold at an average price of $70.82, for a total transaction of $9,925,918.74. Following the sale, the chief financial officer owned 1,155,967 shares in the company, valued at $81,865,582.94. The trade was a 10.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 551,832 shares of company stock valued at $34,940,037. 8.40% of the stock is currently owned by company insiders.

About Rocket Lab

Rocket Lab is a space company that provides launch services and spacecraft and satellite systems for commercial, civil, and national security customers. Founded in 2006 by Peter Beck, the company operates internationally, with headquarters in Long Beach, California, and launch operations in New Zealand and the United States.

Its launch business centers on Electron, a small orbital rocket designed to carry satellites to space, and HASTE, a suborbital vehicle used for hypersonic test missions.

Want to see what other hedge funds are holding RKLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rocket Lab Corporation (NASDAQ:RKLB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.